MedPath

Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation

Not Applicable
Recruiting
Conditions
Neuropathy, Diabetic
Neuropathy;Peripheral
Neuropathy, Painful
Interventions
Device: Somatosensory feedback
Registration Number
NCT06471517
Lead Sponsor
Institute Mihajlo Pupin
Brief Summary

Neuropathy refers to a condition that results from damage to the peripheral nerves.The most common cause of it is diabetes mellitus, metabolic disorder that affects more than 422 million individuals worldwide, putting a huge strain on the healthcare system and up to 50% of these individuals will develop neuropathy. Peripheral neuropathy is characterized by sensory nerve abnormalities such as an impaired sense of touch. Sensory loss in feet can lead to functional deficits during gait, low balance, and increased risk of falls and is considered the strongest risk factor for diabetic foot ulceration. Moreover, these patients usually also suffer from neuropathic pain, which is believed to be associated with aberrant sensory input.

With this in mind, the study aims to understand the effects of restoring sensation lost to neuropathy using transcutaneous electrical stimulation. Additionally, the investigators aim to understand if electrical stimulation of the damaged nerves can reduce health consequences such as chronic pain.

To achieve this, the investigators have developed a wearable sensory restoration system that can restore lost sensation with non-invasive, precisely controlled electrical stimulation through electrodes integrated into the sock garment. A system is composed of a system controller that communicates via Bluetooth with force-sensitive insoles placed in the shoes and neurostimulators directly connected to electrode array socks. Based on the insole recordings the stimulation parameters are defined in real-time, making it a closed-loop system for restoring somatotopic sensory feedback.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Diagnosed polyneuropathy
  • Ability to stand and walk unassisted.
  • Sensory loss in the feet
Exclusion Criteria
  • Open ulcers on the feet
  • Pregnancy
  • History of or current psychological diseases that include schizophrenia and major depression
  • Hypersensitivity to electrical stimulation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Somatosensory feedbackSomatosensory feedbackSomatotopic sensory feedback elicited by transcutaneous electrical stimulation (TENS) will be provided to the patients using electrodes integrated into the garment sock. The closed loop system provides stimulation parameter change based on the data recorded with sensorized insoles.
Primary Outcome Measures
NameTimeMethod
Location of evoked sensationsthrough study completion, an average of 2 weeks

Document where on the feet the subject perceives the stimulation locations.

Stimulation threshold range to a variety of stimulus parametersthrough study completion, an average of 2 weeks

Quantify the lower and higher threshold (charge) stimulus eliciting somatosensory sensation

Safety of the participantsup to 1.5 months

Number of adverse events possibly, probably or causally related to the procedure or device

Secondary Outcome Measures
NameTimeMethod
Impact of providing sensory feedback on neuropathic pain from pre treatment to post treatmentup to 1.5 month

Demonstrating the change in level of neuropathic pain using Neuropathic pain symptoms inventory (NPSI) questionnaire. It will be assessed before starting the treatment, every session of the treatment, one day after the last session, one week after the last session, one month after the last session

Impact of providing sensory feedback on volume of oxygen (VO2) consumption (metabolic consumption) during walkingthrough study completion, an average of 2 weeks

Demonstration of statistically relevant change of metabolic cost (mLO2/kg/meter) while walking with provided sensory feedback compared to the case without the provided sensory feedback.

Treatment Satisfaction Measurethrough study completion, an average of 2 weeks

The subject ranks the treatment satisfaction using a Likert-scale.

Impact of providing somatosensory feedback on mobilitythrough study completion, an average of 2 weeks

Demonstration of statistically relevant change of kinematic parameter (m/s) while performing mobility tests (climbing and descending stairs, 10 meter walking test, 6 minutes walking test etc.) with provided sensory feedback compared to the case without the provided sensory feedback.

Impact of providing sensory feedback on dual-task gait assessmentthrough study completion, an average of 2 weeks

Demonstration of statistically relevant change of dual-task gait assessment score while walking with provided sensory feedback compared to the case without the provided sensory feedback.

Impact of providing somatosensory feedback on balancethrough study completion, an average of 2 weeks

Demonstration of statistically relevant change of score in 4-stage balance test with closed eyes with provided sensory feedback compared to the case without the provided sensory feedback.

Impact of providing sensory feedback on neuropathic pain from pre treatment to post treatment and before and after each sessionup to 1.5 month

Demonstrating the change in level of neuropathic pain using visual analog scale (VAS). It will be assessed every day (overall level of pain), before each session, after each session

Impact of providing sensory feedback on tactile acuitythrough study completion, an average of 2 weeks

Measured with Two-Point discrimination test. While blindfolded, the patient is repetitively touched with either one or two pins (fixed distance) and asked to tell how many pins he/she feels.

Impact of providing sensory feedback on sensitivity (Quantitative sensory testing)through study completion, an average of 2 weeks

Demonstrating if there is a change in quantitative sensory testing score when treatment is provided

Impact of providing superficial stimulation on feet swellingthrough study completion, an average of 2 weeks

Figure-of-Eight method - A tension-controlled measuring tape is wrapped around the ankle and foot for the measurement

Impact of providing sensory feedback on proprioceptionthrough study completion, an average of 2 weeks

Proprioceptive displacement test: patients will be asked to locate the big toe of their feet while not being able to see it. The distance between real and reported placement will be assessed.

Trial Locations

Locations (1)

Clinics for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia

🇷🇸

Belgrade, Serbia

© Copyright 2025. All Rights Reserved by MedPath